Mariner’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$806K Buy
16,971
+10,045
+145% +$450K ﹤0.01% 2123
2025
Q4
$220K Sell
6,926
-1,557
-18% -$48.6K ﹤0.01% 3097
2025
Q3
$239K Buy
8,483
+134
+2% +$4.06K ﹤0.01% 3010
2025
Q2
$307K Sell
8,349
-3,069
-27% -$106K ﹤0.01% 2709
2025
Q1
$449K Sell
11,418
-141
-1% -$6.35K ﹤0.01% 2297
2024
Q4
$537K Buy
11,559
+2,812
+32% +$127K ﹤0.01% 2139
2024
Q3
$397K Buy
8,747
+2,231
+34% +$106K ﹤0.01% 2333
2024
Q2
$321K Sell
6,516
-4,438
-41% -$181K ﹤0.01% 2394
2024
Q1
$376K Buy
10,954
+3,602
+49% +$130K ﹤0.01% 2248
2023
Q4
$271K Buy
+7,352
New +$170K ﹤0.01% 2437
2022
Q4
Sell
-9,471
Closed -$334K 2841
2022
Q3
$334K Buy
+9,471
New +$402K ﹤0.01% 1700

Other funds holding TWST

Mariner's TWST Position: Q1 2026 in Review

Mariner increased its Twist Bioscience (TWST) stake by 145% in Q1 2026, buying an estimated $450K and bringing the position to 16,971 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Mariner first reported a position in TWST in Q3 2022 and has held it in 11 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Mariner held 16,971 shares of Twist Bioscience worth $806K as of Q1 2026.
  • Mariner bought 10,045 Twist Bioscience shares in Q1 2026, an estimated $450K.
  • Twist Bioscience made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2123 holding.
  • Mariner first reported a position in Twist Bioscience in Q3 2022 and has held it in 11 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.